For motor and sensory deficits in spinal cord injury, acrolein found to be a novel therapeutic target

Acrolein, a highly reactive unsaturated aldehyde, has been shown to play a major role in the secondary injury by contributing significantly to both motor and sensory deficits.

Prof. Riyi Shi, who comes from University of Purdue in USA will highlight the recent developments in the understanding of the mechanisms of acrolein in motor and sensory dysfunction in animal models of spinal cord injury, and will also discuss the therapeutic benefits of using acrolein scavengers to attenuate acrolein-mediated neuronal damage following spinal cord injury.

The relevant study has been published in Neural Regeneration Research (Vol. 9, No. 7, 2014).

Contact our news editors

For any corrections of factual information, or to contact our editorial team, please see our contact page.

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms of use.